mergers

Plug Power Stock Falls. It Lost More Money Than Expected Because of Natural Gas Prices.

[ad_1] Text size Plug Power reported a first-quarter loss of 27 cents per share. Analysts expected a loss of 16…

3 years ago

Zillow Stock Tumbles After Selling More Homes Than Expected. Here’s Why.

[ad_1] Text size Zillow says it has 1,300 homes left in its inventory, most of which have sold or are…

3 years ago

Berkshire Hathaway May Have Sold Verizon, Bought $10 Billion of Financials

[ad_1] Text size Warren Buffett's Berkshire Hathaway said it incurred $739 million of realized losses on equity sales in the…

3 years ago

Warren Buffett Says Markets Have Become a ‘Gambling Parlor’

[ad_1] OMAHA, Neb.—As recently as February, Warren Buffett lamented he wasn’t finding much out there that was worth buying. That is…

3 years ago

Warren Buffett Opines on Investments, Inflation, and Politics

[ad_1] OMAHA, Neb.—The Berkshire Hathaway annual shareholders meeting returned to a live, in-person format for 2022, after a two-year pandemic…

3 years ago

Berkshire Hathaway First Quarter Operating Profits Edged Higher as Buybacks Slowed

[ad_1] Text size Warren Buffett tells investors to focus on operating profits, not overall earnings. David Paul Morris/Bloomberg Berkshire Hathaway…

3 years ago

Opinion: Dump Buffett as Berkshire’s chairman? That’s exactly what’s wrong with so many shareholder proposals this year

[ad_1] This coming weekend, Warren Buffett hosts his famed annual meeting of Berkshire Hathaway BRK.A, -1.66% BRK.B, -1.87% shareholders in…

3 years ago

Twitter Re-Examines Elon Musk’s Bid, May Be More Receptive to a Deal

[ad_1] Twitter Inc. TWTR 3.93% is re-examining Elon Musk’s $43 billion takeover offer after the billionaire lined up financing for…

3 years ago

Musk Says Twitter’s Board Owns Almost No Stock. Here’s How It Compares With Tesla.

[ad_1] Twitter’s directors are granted $225,000 of restricted stock units, plus at least $50,000 in cash, annually. David Paul Morris/Bloomberg…

3 years ago

Antares Pharma Stock Soars After $960 Million Halozyme Buyout

[ad_1] Text size Nasdaq-listed Antares Pharma is being bought by Halozyme Therapeutics in a deal valued at $960 million. Michael…

3 years ago